Monday, May 11, 2026




In Detail Full day, Monday, May 11, 2026, Timezone: America/Chicago


A Cancer Driven by Ultra-Rare Mutation Gets Its First FDA-Approved Therapy

Frank Vinluan / medcitynews - Partner Therapeutics’ Bizengri is now FDA approved for treating advanced cases of cholangiocarcinoma driven by NRG1 gene fusions. Partner acquired U.S. rights to this bispecific antibody from Merus in 2024. The post A Cancer Driven by Ultra-Rare Mutation …

AI Summary: The FDA approved zenocutuzumab‑zbco for NRG1‑fusion–positive cholangiocarcinoma, delivering the first cleared therapy for cancers driven by this ultra‑rare genomic alteration. Trial data showed meaningful responses in heavily pretreated patients, prompting regulators to greenlight a precision option that offers targeted benefit where none existed — a small‑population win for genomic oncology.

#healthcare #pharmaceuticals #biotech #drugdevelopment #fda #oncology #cancerresearch #clinicaltrials

1 month / oncodaily

1 month / oncodaily

1 month / medicalxpress

2 months / oncodaily


Back to Top / Mon, May 11, 2026, 3:23 pm / permalink 23594 / 6 stories in 1 month /



Study reveals how parenting styles shape babies' willingness to help others

medicalxpress - New research from Durham University shows that the way parents instruct and encourage infants to help plays a key role in how helping behavior develops, and that these approaches vary across cultures.

AI Summary: The RESET‑C trial tested one preoperative dose of pembrolizumab in localized mismatch repair‑deficient colon cancer and recorded unexpectedly high tumor responses, with several patients remaining cancer‑free for nearly three years. The dramatic neoadjuvant activity suggests immune priming could reshape perioperative strategies and raises questions about surgery timing and organ preservation.

#pharmaceuticals #biotech #drugdevelopment #oncology #cancerresearch #clinicaltrials #genetics #diagnostics

7 wks / oncodaily

7 wks / oncodaily

1 month / nature

1 month / oncodaily

1 month / oncodaily

1 month / oncodaily

2 months / medicalxpress

2 months / sciencedaily


Back to Top / Mon, May 11, 2026, 2:21 am / permalink 23550 / 8 stories in 2 months /



500-year-old gold dental bridge is earliest known oral care of its kind in Scotland — and it likely held a fake tooth

livescience - Archaeologists discovered the 20-karat-gold dental wire in the lower jaw of a middle-aged man who lived around 500 years ago in Scotland.

AI Summary: Archaeologists uncovered what appears to be the earliest known gold dental bridge in Scotland, dating roughly four to five centuries ago and likely fitted with a faux tooth. The discovery sheds light on historic dental practice, craftsmanship and status signaling—proof that vanity and dental innovation are nothing new.

#healthcare #medicaldevices

7 wks / livescience

1 month / livescience

2 months / livescience

2 months / livescience

2 months / discovermagazine


Back to Top / Mon, May 11, 2026, 12:21 am / permalink 23545 / 6 stories in 2 months /



With Commissioner Under Pressure, F.D.A. Opens Door to Flavored Vapes

Christina Jewett / nytimes - Though illicit e-cigarettes have flooded in from China, the new policy could allow major tobacco companies to sell from prime shelf space at thousands of stores.

AI Summary: Facing mounting pressure, the FDA has signaled authorization of fruit‑flavored vaping products for adults, a regulatory shift framed as adult access and harm reduction. Public‑health experts warn the move risks increasing youth appeal and reignites debate over flavors, enforcement, and whether potential population‑level tradeoffs were adequately considered.

#healthcare #publichealth #governmentpolicy #fda #behavioralhealth #healthdisparities #adolescenthealth

7 wks / oncodaily

1 month / medicalxpress

2 months / medicalxpress

2 months / medicalxpress


Back to Top / Mon, May 11, 2026, 12:21 am / permalink 23544 / 6 stories in 2 months /







StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Healthcare Finance, Drug Pricing, Infant Health, Infectious Disease and look for the RSS link.

More StackHealth





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.